XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT - USD ($)
shares in Thousands, $ in Thousands
Ordinary Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balances at Dec. 31, 2018 $ 1 $ 960,721 $ (166) $ (1,012,145) $ (51,589)
Balances (in shares) at Dec. 31, 2018 55,681        
Increase (Decrease) in Stockholders' Equity          
Proceeds from ESPP purchases   2,605     2,605
Proceeds from ESPP purchases (in shares) 145        
Employee share-based compensation expense   23,519     23,519
Issuance of restricted shares (in shares) 689        
Option exercises   2,545     2,545
Option exercises (in shares) 122        
Repurchase of shares to satisfy tax withholding   (2,181)     (2,181)
Net unrealized gain/loss on marketable securities     295   295
Net loss       (112,418) (112,418)
Balances at Jun. 30, 2019 $ 1 987,209 129 (1,124,563) (137,224)
Balances (in shares) at Jun. 30, 2019 56,637        
Balances at Mar. 31, 2019 $ 1 971,508 (36) (1,084,725) (113,252)
Balances (in shares) at Mar. 31, 2019 56,122        
Increase (Decrease) in Stockholders' Equity          
Proceeds from ESPP purchases   2,605     2,605
Proceeds from ESPP purchases (in shares) 145        
Employee share-based compensation expense   11,298     11,298
Issuance of restricted shares (in shares) 263        
Option exercises   2,292     2,292
Option exercises (in shares) 107        
Repurchase of shares to satisfy tax withholding   (494)     (494)
Net unrealized gain/loss on marketable securities     165   165
Net loss       (39,838) (39,838)
Balances at Jun. 30, 2019 $ 1 987,209 129 (1,124,563) (137,224)
Balances (in shares) at Jun. 30, 2019 56,637        
Balances at Dec. 31, 2019 $ 1 1,024,614 145 (1,248,600) $ (223,840)
Balances (in shares) at Dec. 31, 2019 57,015       57,015
Increase (Decrease) in Stockholders' Equity          
Net proceeds from sale of ordinary shares   139,915     $ 139,915
Net proceeds from sale of ordinary shares (in shares) 5,500        
Proceeds from ESPP purchases   2,545     2,545
Proceeds from ESPP purchases (in shares) 168        
Employee share-based compensation expense   31,861     31,861
Issuance of restricted shares (in shares) 1,097        
Option exercises   936     936
Option exercises (in shares) 41        
Repurchase of shares to satisfy tax withholding   (7,948)     (7,948)
Repurchase of shares to satisfy tax withholding (in shares) (306)        
Net unrealized gain/loss on marketable securities     135   135
Net loss       (145,940) (145,940)
Balances at Jun. 30, 2020 $ 1 1,191,923 280 (1,394,540) $ (202,336)
Balances (in shares) at Jun. 30, 2020 63,515       63,515
Balances at Mar. 31, 2020 $ 1 1,173,204 512 (1,331,653) $ (157,936)
Balances (in shares) at Mar. 31, 2020 63,004        
Increase (Decrease) in Stockholders' Equity          
Proceeds from ESPP purchases   2,545     2,545
Proceeds from ESPP purchases (in shares) 168        
Employee share-based compensation expense   16,585     16,585
Issuance of restricted shares (in shares) 353        
Option exercises   733     733
Option exercises (in shares) 33        
Repurchase of shares to satisfy tax withholding   (1,144)     (1,144)
Repurchase of shares to satisfy tax withholding (in shares) (43)        
Net unrealized gain/loss on marketable securities     (232)   (232)
Net loss       (62,887) (62,887)
Balances at Jun. 30, 2020 $ 1 $ 1,191,923 $ 280 $ (1,394,540) $ (202,336)
Balances (in shares) at Jun. 30, 2020 63,515       63,515